PedAM
Pediatric Disease Annotations & Medicines
| Disease | lung cancer |
| Symptom | C0746883|febrile neutropenia |
| Sentences | 6 |
| PubMedID- 21773751 | In this study, we tried to identify the risk factors for refractory febrile neutropenia in patients with lung cancer. |
| PubMedID- 24679653 | We assessed the efficacy and safety of cefepime monotherapy (1 g intravenously every 8 h) for febrile neutropenia in patients with lung cancer in a multi-institutional phase ii study. |
| PubMedID- 21707992 | In view of the scarcity of data on lung cancer patients with febrile neutropenia, we performed a retrospective study of the microbiological characteristics of cases recorded in three medical centers in the picardy region of northern france. |
| PubMedID- 23173291 | febrile neutropenia in lung cancer patients. |
| PubMedID- 23053498 | In the present study, we searched for predictive factors for the failure of the initial antimicrobial agents used for febrile neutropenia (fn) in patients with lung cancer. |
| PubMedID- 26434104 | Pentraxin-3 as a biomarker for febrile neutropenia in patients with lung cancer. |
Page: 1